Objective: The present studies were undertaken to identify apoptosis in cardiomyocytes of genetic hypertension and to study the relationship among apoptosis, aging and blood pressure, and the effect of angiotensin-converting enzyme (ACE) inhibitors on apoptosis. Methods: Apoptosis in the hearts of spontaneously hypertensive rats (SHR) was identified by electron microscopy (EM) and DNA laddering, and quantified from age 3 weeks to 64 weeks in comparison with normotensive rats (WKY). Fibroblasts and protein products of Bcl-2 and Bax were measured by quantitative immunohistochemistry. SHR were treated with ramipril, an ACE inhibitor. Results: The results showed that: (1) ultrastructural characteristics of apoptosis were observed in cardiomyocytes of SHR, with shrinkage of the cell and condensation of the cytoplasm and chromatin. A DNA ladder was shown; (2) a significant increase in apoptosis in SHR began as early as age 4 weeks and reached a plateau at 16 weeks and maintained at high levels up to 64 weeks. Blood pressure (BP) in SHR started to increase significantly at age 5 weeks; (3) fibroblasts were significantly increased in the heart of SHR; (4) the ratio of Bcl-2 / Bax was significantly reduced in SHR; and (6) ramipril effectively reduced apoptosis and fibroblasts, and increased the ratio of Bcl-2 / Bax. Conclusion: Apoptosis occurs in the cardiomyocytes of genetic hypertension although fibroblasts are increased, and a significant, age-dependent increase in apoptosis is observed. The increase in apoptosis occurs before the difference in blood pressure is detectable. The ACE inhibitor ramipril may be useful for prevention of apoptosis in the heart.
Introduction
There are a variety of pathological conditions that eventually lead to heart failure. Hypertension is one of the very Apoptosis or program cell death is a gene-controlled cell important conditions. Hypertension can result in diastolic suicide [1, 2] . The role of apoptosis in diverse physiological and systolic heart failure. However, how this clinical processes and in a variety of pathological conditions has setting eventually results in heart failure is unknown. We received considerable attention in recent years [1] [2] [3] .
hypothesise that apoptosis could be involved in the mechaApoptosis in heart and vasculature has recently been nism that causes the progressive loss of cardiomyocytes in recognized.
the failing heart of hypertension. Recently, some investigators have suggested that apop-
The most characteristic features of apoptosis are the tosis may play a key role in heart disease, particularly heart morphological changes recognisable by electron microfailure [4] . The fundamental issue in heart failure is what scopy (EM) and the internucleosomal cleavage of genomic causes the progressive loss of cardiomyocytes in a chronic DNA into fragments that are discrete multiples of 185-200 process. As a death process induced by internal signalling bp that produce a typical DNA ladder after agarose gel triggered by imbalance in the biological conditions, apopelectrophoresis (DNA laddering) [1, 2] . Ultrastructural tosis could be the cause for the loss of cardiomyocytes.
characteristics of apoptosis, e.g. condensation and margination of chromatin and shrinkage of the cell, which can only be clearly seen under EM, have been demonstrated in certain cells, mostly tumor cells. However, the ultrastruccontrol SHR (n56) and WKY (n56) with distilled water, tural morphology of apoptosis in cardiomyocytes of a from 3 to 10 weeks of age. The other reagents were from hypertensive heart has not been reported. A recent study on Sigma Chemical (St Louis, MO) unless otherwise stated. infarct hearts with EM [5] has shown that the previous claimed 'apoptotic' myocytes in the infarct area of hearts 2.2. Transmission electron microscopy (EM) may be oncotic myocytes with DNA fragmentation. That study highlights the importance of using EM for studies on Preparation of cardiac tissues of SHR or WKY was apoptosis [6] . Since the apoptotic morphology remains the performed as previously described [8] . Briefly, portions of gold standard for identification of apoptosis, it is necessary cardiac tissues from SHR or WKY were fixed in 2.5% to investigate this issue in the cardiomyocytes of a glutaraldehyde in 0.1 M PBS at 48C overnight. The fixed hypertensive heart. tissues were washed with distilled water, dehydrated Angiotensin-converting enzyme (ACE) inhibitors have through graded acetone, and embedded in Araldite-Epon been routinely used to treat heart failure and hypertension.
resin (CIBI -GEIGY, Lane Cove, NSW, Australia). Thin Prevention of cardiovascular remodelling has been prosections were cut and stained with saturated uranyl nitrate posed as the key mechanism of the efficacy of these drugs and Reynolds lead citrate, and viewed in a JEOL-1200 EX [7] . However, the precise mechanism of how these drugs electron microscope (JEOL, Tokyo, Japan). prevent cardiovascular remodelling is not very clear. It is known that apoptosis plays an important role in tissue 2.3. DNA laddering remodelling and could also be involved in cardiovascular 32 remodelling in pathological conditions. We hypothesise DNA extraction and electrophoresis of a PdCTP-lathat prevention of apoptosis could be one of the mechabelled DNA fragments (DNA laddering) was performed as 32 nisms for the efficacy of ACE inhibitors. Ramipril, an previously described [8] . A 10-ml a PdCTP labelled (see ACE inhibitor, has a long-acting effect, can be used once below) DNA sample (about 100 ng) was precipitated for 2 daily and is welcomed by clinicians and patients. Whether h in 2208C ethanol containing 0.3 M sodium acetate and ramipril has an effect on apoptosis is unknown.
0.01 M MgCl (final concentration) and centrifuged for 30 2 In the present studies, we used spontaneous hypertensive min, 48C, at 12 000 g. The precipitated, labelled DNA was rat (SHR) as a model (a genetic hypertensive model) to washed twice with 70% cold ethanol and unincorporated 32 study the following issues: (1) Does apoptosis occur in the a PdCTP removed. The labelled DNA was resuspended genetic hypertensive heart? (2) If yes, how is it related to in TE buffer (10 mM Tris-HCl pH 8, 1 mM EDTA), the age and the development of hypertension? (3) Can the mixed with 5 ml of loading buffer (0.25% bromophenol rate of apoptosis be changed by the ACE inhibitor ramipblue, 0.25% xylene cyanol FF, 15% ficoll) and elecril? We use the spontaneously hypertensive model as an trophoresed for 3 h at 5.0 v / cm in 1.0% agarose gel using approach to study the issue of apoptosis in hypertension, 0.5X TBE buffer (45 mM Tris-borate, 1 mM EDTA) as because over 90% of patients with hypertension have running buffer. The gel was removed and dried in a spontaneous hypertension (or essential hypertension).
Gel-Drying Frame (Kem-En-Tec, Haraldsgade, Denmark) These studies may also provide necessary information for following gel equilibration with 3% of glycerol for 1 h. our future studies on other models of hypertension.
Dried gel was sealed in plastic wrap and exposed to Kodak X-Omat film (Eastman Kodak, Rochester, NY) with an intensifying screen for 2-3 h at 2708C.
Methods

Saturation labelling assay 2.1. Animals and reagents
Saturation labeling of the 39 end of apoptotic DNA Rats (72 male SHR and 60 WKY) were obtained from fragmentations from the cardiac tissues of SHR and WKY the animal house of Austin Hospital, Heidelberg, Australia. was performed as previously described [8] . A 20-ml Ethic approval for using these animals has been granted by reaction mixture containing 4 ml of 5X buffer (BoehringAnimal Ethic Committee of Austin Hospital. BP was Mannheim, Germany), 2 ml of 2.5 mM CoCl 1000 ng . After taking 2 ml as background, 20 U TdT Pharmaceutical, was used to treat SHR, with untreated (Pharmacia, Uppsala, Sweden) were added. The reaction SHR and WKY as controls. Young SHR (n56) were was proceeded for 60 min at 378C, and stopped by adding 32 treated with ramipril (1 mg / kg, once daily), and theincorporated into 39-ends of DNA strand breaks was of fibroblasts (Dako Australia, Botany, NSW; 250 pg / ml performed as follows: 2 ml labeling sample was added to diluted in 0.05 M TrisCl pH 7.4 containing 1% BSA). 48 ml of 0.5 mg / ml calf thymus DNA as carrier. A 5-ml Peptide neutralization was used as our negative control. aliquot of the mixture was spotted onto a glass-fibre filter Following three 10-min rinses to remove the excess (Whatman 2.5 cm GF / C) for assessing total radioactivity.
antibody, a 5-min incubation with a biotinylated anti-rabbit The labelled DNA was precipitated by 1.0 ml 10% (V/ W) antibody at 1:200 dilution was used to incubate the tissue trichloroacetic acid (TCA) for 10-15 min on ice. The sections. Once more, three rinses in 0.05 M TrisCl pH 7.4 32 unincorporated a PdCTP was eluted through a second for 10 min were performed to remove excess biotinylated glass-fibre filter by washing four times with 3 ml 10%
antibodies. In the following 5-min incubation, a strep-TCA, and three times with 3 ml 100% ethanol. The filter tavidin molecule was used to conjugate to alkaline phoswas dried and placed into a vial. The amount of incorpophatase at a 1:200 dilution. Subsequently, three 10-min 32 rated a PdCTP was detected by counting for 5 min in a rinses in 0.05 M TrisCl pH 7.4 in a gentle rocking manner 300 CD liquid scintillation counter (Packard Instrument.
was performed. The tissue sections were then equilibrated All experiments were repeated at least three separate times in 100 mM TrisCl, pH 9.5 containing 100 mM NaCl for 2 and in triplicate for each sample.
min. To provide chemiluminescence, the sections were incubated with CDP-Star substrate (diluted at 1:200 in 100 mM TrisCl, pH 9.5, 100 mM NaCl), for five min. The 2.5. Calculations substrate included 10 mM Levamisole to inhibit endogenous alkaline phosphatases. The sections were then dried in The details of calculation have been described previousan oven at 208C and then exposed for 10 min under ly [8] . The L of the saturation labeling assay was max Mamoray MR5 X-ray film. The following images were obtained as following:
analyzed using a microscopy computer imaging devise a PdCTP/ mg DNA) ment groups and ages (experiments). Statistical signifi-K 5kinetic parameter521 / slope (see Fig. 2B ) cance was taken at a level of P,0.05. (Fig. 1b, c) . A normal cardiomyocyte obtained from WKY was used as control. The The quantity of Bcl-2, Bax and fibroblasts were denucleus (N) in the normal cell (Fig. 1a) showed even termined by a modified objectively quantitative immunodistribution of chromatin and a normal nucleolus (n). An histochemistry, originally developed in our laboratory [10] .
apoptotic cell from SHR illustrates early ultrastructural The hearts were obtained at age 11 weeks. The cardiac changes of apoptosis (Fig. 1b) . The nucleus (N) showed tissues and coronary arteries were cut into tissue sections shrinkage characterized by the appearance of a clear gap of 14 mm. The sections were fixed / dehydrated in acetone around the nucleus and contained small marginated elecat room temperature for 10 min, dried, and rehydrated in tron dense chromatin masses (arrow). Clumped ill-defined 0.05 M TrisCl pH 7.4 for 5 min before an incubation with nuclear chromatin was also present (arrowhead). Another 20% swine serum for 20 min in order to decrease cell (Fig. 1c) manifests further advanced apoptosis comnonspecific binding. The sections were then incubated with pared with the cardiomyocyte in Fig. 1b . The nucleus (N) antibodies to Bcl-2, Bax, or fibroblasts with a specific showed deep condensation that was revealed by the monoclonal antibody to the beta-subunit of prolyl-4-hyappearance of a large gap around the nucleus and invaginadroxylase of fibroblasts, which is a specific cell component tions of the nucleolemma, and contained large sharply by guest on May 13, 2015
Downloaded from marginated electron dense chromatin masses that abutted the nuclear envelope as well as large clumped ill-defined nuclear chromatin. These results identify that the cardiomyocytes of SHR undergo apoptosis. Apoptosis in SHR was also shown by the electrophoresis of DNA ladder pattern that showed a typical nucleosome ladder in cardiac tissue obtained from SHR (Fig. 2, lane 1,3 ).
Quantification of DNA fragments in the cardiac tissues of SHR
DNA fragments of the cardiac tissues in SHR and WKY were quantitated at age 3, 4, 6, 8, 16, 32 and 64 weeks. The results showed that there was a significant age-dependent increase in apoptosis in SHR, and the labeling of DNA breaks in SHR started to increase significantly at age 4 weeks (L : 12.3460.94 pmol / mg DNA in SHR vs. (Fig. 3a) . The values were maintained at high levels up to 64 weeks (39.3562.5 in SHR vs. 11.4461.78 in WKY, n56, P,0.01). When the DNA from WKY was tested, there was no significant increase in the labeling of DNA breaks with increasing age, although the trend showed a slight gradual increase in apoptosis from age 3 weeks to 64 weeks (the values of L were 9.9060.81 pmol / mg DNA at 3 weeks vs. (Fig. 3a) . Meanwhile, the blood pressure of these SHR started to increase significantly at age 5 weeks, and reached a plateau at 16 weeks (Fig. 3b) . Interestingly, the increase in DNA fragmentation in SHR was earlier than the occurrence of the significant increase in BP. n56, Fig. 5 ). Ramipril increased the quantity of Bcl-2 proteins and reduced that of Bax (P,0.01, n56, Fig. 5 ).
Effect of ACE inhibitor on apoptosis
The DNA fragmentation of SHR treated with ramipril was significantly reduced (L , 12.9462.30 pmol / mg max DNA) compared to untreated SHR (L , 27.2062.30 max pmol / mg DNA) (P,0.01) (Fig. 6) , while there was no 
Fibroblasts in the hearts
The results showed that the quantity of fibroblasts was significantly increased in the hearts of SHR (P,0.01, n56), compared to those of WKY (Fig. 4) . Treatment of SHR with ramipril significantly reduced the quantity of fibroblasts compared with untreated SHR (P,0.01, n56) (Fig. 4) . by guest on May 13, 2015 Downloaded from increased in the heart of SHR; (5) the ratio of Bcl-2 / Bax was significantly reduced in SHR; and (6) ramipril effectively reduced apoptosis and fibroblasts, and increased the ratio of Bcl-2 / Bax.
We have revealed a typical morphology of apoptosis in the cardiomyocytes of SHR. The results clearly demonstrate that apoptosis occurs in the cardiomyocytes of SHR. Since we have detected apoptosis in SHR by four different methods (electron microscopy, DNA laddering, quantification of DNA fragmentation, and quantification of apoptotic regulatory proteins), we feel confident that apoptosis does occur in genetic hypertension.
By quantification, the present studies demonstrate the time course for the development of apoptosis, hypertension and age. It indicates clearly that apoptosis is increased in genetic hypertension and is associated with aging. The studies also demonstrate that the increase in apoptosis occurs earlier (4 weeks) than does BP (5 weeks). There are two explanations for this phenomenon. One is the tail-cuff apoptosis may not depend on BP but on other factors such as neurohumoral factors that also cause hypertension. 11.8061.0 pmol / mg DNA) (n56, P.0.1) (Fig. 6) .
Studies by other investigators have shown that angiotensin Meanwhile, the ratio of the heart:body weight as an index II (AII), a blood pressure producer, can cause apoptosis in of cardiac hypertrophy was significantly different between cultured cardiomyocytes [11] . This direct evidence suguntreated SHR and treated SHR (P,0.05), and no signifigests that apoptosis in SHR might not, or at least not cant difference between WKY and SHR treated with solely, depend on blood pressure. ramipril (P.0.10). Results also displayed that there was One question is in which cell types did the increased no effect of the ramipril treatment on body weight (n56, apoptosis occur? The heart consists of many cell types. P.0.20) over the treatment period from 3 to 10 weeks of Besides cardiomyocytes, fibroblasts are another major age. The untreated SHR showed a steady increase in BP, group of cells in heart. It could be possible that the characteristic of the developmental phase of hypertension. increased apoptosis is caused by an increase in apoptosis At age 10 weeks, BP was significantly lower in the group of fibroblasts. However, in the present studies the quantity treated with ramipril than in untreated SHR (the untreated, of the fibroblasts was actually increased but not reduced in 18867.0 mmHg; the ramipril-treated, 12865.2 mmHg, SHR. We believe that the increased apoptosis most likely n56, P,0.001), and there was no significant difference occurs in cardiomyocytes, which has actually been obbetween the ramipril-treated SHR and WKY (WKY, served in our EM results. However, the possibility of 12465.6; the ramipril-treated SHR, 12865.2 mmHg, P.
increased apoptosis in fibroblasts cannot be completely 0.10).
ruled out, because apoptosis and mitosis in fibroblasts may both increase but the balance between them may be in favour of mitosis in this case.
Discussion
The progressive loss of cardiomyocytes in the heart may play a key role in pathogenesis of heart failure (including There are five main findings in the present studies: (1) diastolic and systolic failure). It is well known that adult ultrastructural characteristics of apoptosis in the carcardiomyocytes do not undergo mitosis. Therefore, the lost diomyocyte of SHR were identified by EM and apoptosis cardiomyocytes cannot be re-grown, but can be replaced in SHR was also shown by the biochemical method DNA by other cells such as fibroblasts (In fact, our results did ladder pattern; (2) an age-dependent significant increase in show an increase in fibroblasts in SHR). Studies [12] have apoptosis occurred in SHR from age 4 weeks, reached a been reported that cardiomyocytes are gradually lost in plateau at age 16 weeks and maintained at high levels up aging rat heart, which is accompanied with a gradual to 64 weeks; (3) the increase in apoptosis appeared earlier increase in fibrous tissues, although the cardiomyocyte (age 4 weeks) than did the increase in blood pressure (5 volume is increased (hypertrophy) in the aging heart. The weeks); (4) The quantity of fibroblasts was significantly morphologic changes result in elevated left ventricular by guest on May 13, 2015 Downloaded from end-diastolic pressure and decreased dP/dt [12] , which
